These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 772595)

  • 21. Role of early postnatal dexamethasone in respiratory distress syndrome.
    Mukhopadhyay K; Kumar P; Narang A
    Indian Pediatr; 1998 Feb; 35(2):117-22. PubMed ID: 9707853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of microcirculatory disorders in cardiogenic shock].
    Dunchich LG; Stasiuk NS
    Vrach Delo; 1977 Nov; (11):57-61. PubMed ID: 595562
    [No Abstract]   [Full Text] [Related]  

  • 23. Aortic thrombosis in a neonate: failure of urokinase thrombolytic therapy.
    Corrigan JJ; Jeter M; Allen HD; Malone JM
    Am J Pediatr Hematol Oncol; 1982; 4(3):243-7. PubMed ID: 6756190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the prevention of respiratory distress syndrome of infants due to hyaline membrane disease with plasminogen.
    Ambrus CM; Choi TS; Weintraub DH; Eisenberg B; Staub HP; Courey NG; Foote RJ; Goplerud D; Moesch RV; Ray M; Bross ID; Jung OS; Mink IB; Ambrus JL
    Semin Thromb Hemost; 1975 Jul; 2(1):42-51. PubMed ID: 798269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experience with urokinase in chronic arterial occlusive disease and long-standing phlebothrombosis].
    Trübestein G; Brecht T; Brecht G; Etzel F
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1948-50. PubMed ID: 1030145
    [No Abstract]   [Full Text] [Related]  

  • 26. Arterial occlusion in a preterm infant. Successful non-surgical treatment with urokinase and low-dose heparin.
    Schmidt B; Wais U; Fürste HO; Pringsheim W
    Helv Paediatr Acta; 1982; 37(5):483-8. PubMed ID: 6761316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of hyaline membrane disease with plasminogen. A cooperative study.
    Ambrus CM; Choi TS; Cunnanan E; Eisenberg B; Staub HP; Weintraub DH; Courey NG; Patterson RJ; Jockin H; Pickren JW; Bross ID; Jung OS; Ambrus JL
    JAMA; 1977 Apr; 237(17):1837-41. PubMed ID: 321823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Aqueous estrogens in the management of respiratory distress syndrome.
    Shanklin DR; Wolfson SL
    J Reprod Med; 1970 Aug; 5(2):53-71. PubMed ID: 4330066
    [No Abstract]   [Full Text] [Related]  

  • 29. [Urokinase (in situ) in the case of acute ischemia of the lower limbs (author's transl)].
    Paillot J; Dumontier P; Raynov M; Ott B; Benichoux R
    J Mal Vasc; 1981; 6(1):19-22. PubMed ID: 7026712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Urokinase & streptokinase in pulmonary embolism.
    Simon TL; Bell WR
    Compr Ther; 1976 Aug; 2(8):18-22. PubMed ID: 954386
    [No Abstract]   [Full Text] [Related]  

  • 31. [Proceedings: Ischemic heart disease and plasma fibrinolytic activity. (4). Fibrinolytic enzyme therapy in acute myocardial infarct].
    Sasa H; Mizuguchi K; Futenma S; Nakamura S; Ito K
    Jpn Circ J; 1975 Jul; 39(7):887. PubMed ID: 1160115
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.
    Liggins GC; Howie RN
    Pediatrics; 1972 Oct; 50(4):515-25. PubMed ID: 4561295
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical and biological aspects of urokinase therapy].
    Potron G; Droulle C; Nicaise H; Seys A; Leroux B; Morice JC; Gerard J; Robert JF
    Therapie; 1975; 30(5):695-704. PubMed ID: 1221560
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of hypoxia and reoxygenation on the expression levels of the urokinase-type plasminogen activator, its inhibitor plasminogen activator inhibitor type-1 and the urokinase-type plasminogen activator receptor in human head and neck tumour cells.
    Sprague LD; Tomaso H; Mengele K; Schilling D; Bayer C; Stadler P; Schmitt M; Molls M
    Oncol Rep; 2007 May; 17(5):1259-68. PubMed ID: 17390074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lytic therapy in vitreous haemorrhage.
    Forrester JV; Williamson J
    Trans Ophthalmol Soc U K (1962); 1974 Jul; 94(2):583-6. PubMed ID: 4534194
    [No Abstract]   [Full Text] [Related]  

  • 36. Proceedings: Thrombolytic therapy of deep venous thromboses with urokinase.
    Theiss W; Kriessmann A; Wirtzfeld A
    Thromb Diath Haemorrh; 1975 Nov; 34(2):568-9. PubMed ID: 1198453
    [No Abstract]   [Full Text] [Related]  

  • 37. [Problems in urokinase therapy in cerebral infarction].
    Matsuo T; Matsuo O
    Rinsho Ketsueki; 1978 Oct; 19(10):1475-8. PubMed ID: 739610
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined intravesical therapy with doxorubicin (adriamycin) and urokinase in the management of superficial bladder tumours.
    Khan O; Aherne GW; Williams G
    Br J Urol; 1982 Jun; 54(3):280-2. PubMed ID: 7049304
    [No Abstract]   [Full Text] [Related]  

  • 39. [Letter: Thrombolytic treatment in subacute and chronic pulmonary arterial thrombosis].
    Chiche P; Benaim R; Acar J; Pouget P; Marien C; Samama M
    Nouv Presse Med; 1976 May; 5(22):1428-9. PubMed ID: 934866
    [No Abstract]   [Full Text] [Related]  

  • 40. [Thrombolytic therapy using urokinase: its mechanism and clinical use (author's transl)].
    Sakuragawa N; Takahashi K
    Rinsho Ketsueki; 1977 Jun; 18(6):726-31. PubMed ID: 916203
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.